5 - N1- and N7-substituted sibiriline derivatives and their use as inhibitor of cellular necroptosis. Dimanche-Boitrel, M. T.; Bach, S.; Delehouze, C.; Goekjian, P.; Comte, A. INSERM – CNRS – UCBLyon1 – UPMC ; PCT Int. Appl. 2017, WO2017/064216 (20/04/2017).
4 - Sibiriline derivatives for use for preventing and/or treating disorders associated with cellular necroptosis. Dimanche-Boitrel, M. T.; Bach, S.; Delehouze, C.; Mettey, Y.; Goekjian, P.; Comte, A. INSERM – CNRS – UCBLyon1 – UPMC – Univ. de Poitiers ; PCT Int. Appl. 2017, WO2017/064217 (20/04/2017).
3 - Synthesis of pyrrolo[2,3-b]pyridine compounds, azaindole compounds used in the synthesis of these compounds, their fabrication processes, and their uses. Meijer, L.; Joseph, B.; Liger, F.; Marquet. B. CNRS – UCB Lyon1 ; PCT Int. Appl. 2008, WO 2008/129152 (30/10/2008).
2 - Novel 9H-pyrido[2,3-b]indoles derivatives, method for the production thereof, and the pharmaceutical compositions containingsuch compounds. Joseph, B.; Meijer, L.; Liger, F. CNRS – UCB Lyon1 ; PCT int. Appl. 2006, WO 2006/040451 (20/04/2006).
1 - Composition containing a thiophenic or benzothiophenic compound and exhibiting a pumpNorAinhibitingactivity. Lemaire, M.; Moreau, N.; Fournier Dit Chabert, J.; Marquez, B.; Marquet, B.; Neuville, L.; Pellet-Rostaing, S.; Bouhours, S.; David, E.; Joucla, L. CNRS – UCB Lyon1 – ENSCP ; PCT int. Appl. 2006, WO 2006/018544 (23/02/2006).